Three new studies conducted in South Africa provide insights into the engine that drives HIV transmission in the country.

The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa.
Epa/Maurizio GambariniDecember 21, 2015